Document is current

Any future updates will be listed below

Discontinuation of Azathioprine could be considered in pediatric patients with Crohn’s disease who have sustained clinical and deep remission

Crossref DOI link: https://doi.org/10.1038/s41598-021-04304-6

Published Online: 2022-01-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark